RxDoctor Payments Data

Mustafa Pirzada, MD

Psychiatry · Boca Raton, FLNPI 1306070149

Payments from drug & device makers

$122,409in general payments, 2019–2025

Across 402 payments — averaging $304.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$110K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • AbbVie$2K
  • Corium, LLC$2K
  • Neurocrine Biosciences, Inc.$1K
  • Alkermes, Inc.$1K
  • plus $3K from 15 others

What the payments were for

  • Consulting fees$1,2521%
  • Travel & lodging$2130%
  • Food & beverage$12,40210%
  • Education$1330%
  • Other$108,40889%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$122,409 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$77,240
Medicare patients
59
Services billed
579

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl16$19,975
Bupropion XlBupropion Hcl79$1,243
Venlafaxine Hcl ErVenlafaxine Hcl72$1,191
Desvenlafaxine Succinate ErDesvenlafaxine Succinate32$1,068
Mirtazapine77$978
Buspirone Hcl92$895
Divalproex Sodium ErDivalproex Sodium16$720
Duloxetine Hcl70$641
Lorazepam83$635
Trazodone Hcl115$631
Quetiapine Fumarate47$624
Olanzapine29$573
Escitalopram Oxalate79$570
Aripiprazole19$502
Memantine Hcl25$423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$955$19,97516 claims
Almatica Pharma LLCSertraline Hcl$172$40948 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →